Stock Market Watch

NxStage Medical – Issues in-line guidance for Q4 and FY11

by ·




NxStage Medical, Inc. (NASDAQ:NXTM). Last Market Price: 20.43, Change: -1.99, % Change: (-8.88%). Shares trade in the range of 18.86 – 21.58 dollars. It has a market capitalization of 1.12B dollars, making it a Small Cap Stock and has 54.77M outstanding shares. The company has a beta of 0.8, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is -0.51. It operates in Healthcare sector and belongs to Medical Equipment and Supplies industry. Percentage shares held by institutional investors is 96%. The company has a 52 week Price range (low – high) of $ 16.44 – 27.12. Average volumes of shares traded daily are 541,661. Volume traded in the last session was at 1,500,000, 2.77 times the average volume.

  • Reports Q3 (Sep)
    • Loss of $0.10 per share, in-line with the estimates
    • Revenues rose 24.1% year on year to $55.9 million
  • Company issues in-line guidance for Q4, sees EPS of ($0.08)-(0.10)
  • Company issues guidance for FY11, reaffirms EPS of ($0.36)-($0.43)

For Q2 (Jun ’11), It had a Net profit margin of -10.32%, an Operating margin of -7.41%. Other Key stats and ratios are : Return on average assets of -7.69%, Return on average equity of -14.73%. The organization has an employee strength of 1,600

Consensus Recommendation is a Outperform.


Estimate for sales for the Year Ending Dec-11 show a mean of 213.82 million dollars, an estimate high of 216.53 million dollars and an estimate low of 207.00 million dollars. A year ago the figures stood at 204.28 million dollars.

Estimate for sales for the Year Ending Dec-12 show a mean of 245.16 million dollars, an estimate high of 250.19 million dollars and an estimate low of 222.60 million dollars. A year ago the figures stood at 241.15 million dollars.

Estimate for EPS for the Year Ending Dec-11 show a mean of -0.40 dollars, an estimate high of -0.36 dollars and an estimate low of -0.43 dollars. A year ago the figures stood at -0.30 dollars.

Estimate for EPS for the Year Ending Dec-12 show a mean of -0.12 dollars, an estimate high of 0.00 dollars and an estimate low of -0.34 dollars. A year ago the figures stood at 0.14 dollars.

Sales for Quarter Ending Jun-11 was estimated at 50.91 million dollars, however the actual sales figure stood at 53.77 million dollars, 2.86 million dollars more than estimates.

Sales for Quarter Ending Mar-11 was estimated at 48.98 million dollars, however the actual sales figure stood at 50.56 million dollars, 1.59 million dollars more than estimates.

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...